A Pain-Fee Window Into Painful Neuropathies

Scientists have demonstrated a new technique for detecting a painful nerve condition known as neuropathy, which affects millions of people with diabetes and many other patients as well. The painless technique focuses on tiny structures in the skin known as Meissner corpuscles, which encapsulate the endings of microscopic nerves in our hands, feet, and other [...]

Valeant Pharmaceuticals Starts Phase 2 Retigabine Study For Treatment Of Postherpetic Neuralgia

Valeant Pharmaceuticals International (NYSE:VRX) announced that it has enrolled the first patient in its Phase 2 clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles. “We are eager to investigate whether retigabine, our new novel potassium channel opener, will be effective in treating [...]

MRE Could Provide A Definitive Diagnosis For People With Muscle Pain

An estimated nine million men and women in the United States live with myofascial pain syndrome, a condition marked by pain that permeates muscles in the neck, back and shoulders. The condition is difficult to diagnose and not entirely understood, but research studies indicate that a new imaging technology developed at Mayo Clinic holds promise [...]

QRxPharma Doses First Patients In Phase III Clinical Trial Program For Its ‘Dual Opioid’ Pain Therapy

QRxPharma (ASX: QRX) announced that a number of patients have been treated in the first of several clinical studies to be conducted as part of the Phase III development program for its lead product candidate Q8003IR, an immediate release dual opioid pain therapy. The initial clinical trial is a double-blind, placebo-controlled study designed to compare [...]

QRxPharma Doses First Patients In Phase III Clinical Trial Program For Its ‘Dual Opioid’ Pain Therapy

QRxPharma (ASX: QRX) announced that a number of patients have been treated in the first of several clinical studies to be conducted as part of the Phase III development program for its lead product candidate Q8003IR, an immediate release dual opioid pain therapy. The initial clinical trial is a double-blind, placebo-controlled study designed to compare [...]

Idiopathic Pain Disorders Pathways Of Vulnerability

UroToday.com- Idiopathic pain disorders (IPDs) consist of such conditions as temporomndibular joint disorders, fibromyalgia syndrome, irritable bowel syndrome, chronic headaches, interstitial cystitis, chronic pelvic pain, chronic tinnitus, whiplash-associated disorders, and vulvar vestibulitis. IPSs commonly aggregate as “comorbid” conditions that are characterized by a complaint of pain as well as a mosaic of abnormalities in motor [...]

DEA Ruling Allowing Multiple Prescriptions For Controlled Substances

The American Academy of Pain Medicine (AAPM) supports today’s Drug Enforcement Administration (DEA) ruling, which allows multiple prescriptions for controlled substances when appropriate. This DEA Final Ruling, “Issuance of Multiple Prescriptions for Schedule II Controlled Substances,” was published in the Federal Register on Monday, Nov. 19, 2007. AAPM considers this ruling to be a positive [...]

First Study Of Australia’s High Cost Of Pain Reveals $34 Billion Price Tag

For the first time, a dollar value has been attached to the high cost of pain in Australia in an MBF Foundation funded study that reveals a massive annual cost of $34.3 billion — nearly $11,000 for each of the estimated 3.2 million people grappling with pain. The price tag of pain includes both financial [...]